Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Latest News for: inhibitors

Edit

Apnimed Expands Portfolio of Oral Pharmacotherapies for Sleep and Breathing Diseases Through Acquisition of Global Rights to Patents Covering Sulthiame, a Differentiated Carbonic Anhydrase Inhibitor

PR Newswire 25 Apr 2025
Sulthiame is an investigational, generally well-tolerated oral carbonic anhydrase inhibitor that is designed to restore breathing stability which is often a contributing mechanism in people with OSA.
Edit

ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative R&D Trends for Inflammasome Inhibitors, and Provides ...

Nasdaq Globe Newswire 24 Apr 2025
Inflammasome inhibitors have moved into P2 trials based on preclinical/P1 safety data & promising signals of efficacy. Data read-outs expected beginning H1 ... .
Edit

Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase ...

Business Wire 24 Apr 2025
... New Drug (IND) application of VS-7375, an oral KRAS G12D (ON/OFF) inhibitor for clinical evaluation.
Edit

Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at ...

Business Wire 23 Apr 2025
Furthermore, a joint poster presentation with Oncodesign Services (www.onc .
Edit

Ivonescimab in Combination with Chemotherapy Achieves Statistically Significant Superiority in PFS vs. Tislelizumab (PD-1 Inhibitor) ...

Business Wire 23 Apr 2025
... PD-1 inhibitor, in combination with platinum-based chemotherapy in patients with locally advanced o .
Edit

Tonner Drones Obtains Patent For Inhibitor In The United States (Tonner Drones SA)

Public Technologies 23 Apr 2025
). Tonner Drones Obtains Patent For Inhibitor In The United States. Schiltigheim, April 23th 2025 18.00, Tonner Drones is pleased to announce that its patent for the Inhibitor is granted in the USA ... End of Press-Release. About Tonner Drones ... Warning.
×